RUGGIERO, DONATELLA
 Distribuzione geografica
Continente #
EU - Europa 265
AS - Asia 153
NA - Nord America 64
SA - Sud America 17
AF - Africa 1
Totale 500
Nazione #
RU - Federazione Russa 221
US - Stati Uniti d'America 61
SG - Singapore 52
CN - Cina 37
HK - Hong Kong 20
VN - Vietnam 19
IT - Italia 16
BR - Brasile 12
IN - India 9
KR - Corea 9
CZ - Repubblica Ceca 5
DE - Germania 4
GB - Regno Unito 4
IE - Irlanda 4
AL - Albania 3
AR - Argentina 3
JP - Giappone 3
CA - Canada 2
LT - Lituania 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BD - Bangladesh 1
EC - Ecuador 1
EE - Estonia 1
FI - Finlandia 1
FR - Francia 1
IR - Iran 1
KH - Cambogia 1
MA - Marocco 1
MD - Moldavia 1
MX - Messico 1
NL - Olanda 1
VE - Venezuela 1
Totale 500
Città #
Moscow 85
Singapore 29
Hong Kong 20
San Jose 16
Hefei 11
Santa Clara 10
Hanoi 9
Seoul 9
Bengaluru 7
Ashburn 6
Beijing 6
Dublin 4
Naples 4
Olomouc 4
Tirana 3
Arezzo 2
Boardman 2
Campobasso 2
Caserta 2
Council Bluffs 2
Ho Chi Minh City 2
Lamezia Terme 2
Los Angeles 2
Shenyang 2
Toronto 2
Amsterdam 1
Atlanta 1
Aversa 1
Barquisimeto 1
Bauru 1
Belo Horizonte 1
Blankenburg 1
Brno 1
Bến Tre 1
Caldas Novas 1
Carmo do Rio Claro 1
Castellammare di Stabia 1
Chisinau 1
Columbus 1
Contagem 1
Da Nang 1
Falkenstein 1
Fes 1
Formiga 1
Frankfurt am Main 1
Gravataí 1
Guernica 1
Hai Bà Trưng 1
Haiphong 1
Helsinki 1
Hillsboro 1
Krasnodar 1
La Joya de Los Sachas 1
London 1
Manaus 1
Manchester 1
Mohali 1
Mérida 1
New York 1
Nova Iguaçu 1
Nuremberg 1
Orem 1
Phnom Penh 1
Phủ Lý 1
Pleiku 1
Quilmes 1
Reston 1
San Juan Bautista 1
Santo Antônio do Pinhal 1
Sharjah 1
St Petersburg 1
São Paulo 1
Tallinn 1
Tenente Portela 1
Thrissur 1
Thái Bình 1
Totale 294
Nome #
COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database 133
Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management 133
Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis 113
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database 111
A systematic review and pharmacovigilance analysis of the risk of agranulocytosis associated with metamizole use 12
Pharmacovigilance study on the reporting frequency of atrial fibrillation with immune checkpoint inhibitors: insights from FDA Adverse Event Reporting System 8
Totale 510
Categoria #
all - tutte 1.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.456


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202432 0 0 6 3 5 3 3 1 3 2 3 3
2024/202578 0 3 1 0 10 5 11 6 21 9 4 8
2025/2026400 20 28 22 17 39 198 18 19 24 15 0 0
Totale 510